InvestmentJun 15, 2026, 08:41 AM
Splash Beverage Group invests CDN$300K in Avicanna for cannabinoid shift
AI Summary
Splash Beverage Group announced a CDN$300,000 strategic investment in Avicanna Inc., a commercial-stage cannabinoid-based biopharmaceutical company. This investment supports Splash's previously announced transformation into a cannabinoid-based health, wellness, and healthcare-focused platform. Splash acquired 2,000,000 common shares and 1,000,000 warrants in Avicanna, aiming to leverage Avicanna's sophisticated platform, clinical development, and healthcare system integration for the evolving medical cannabinoid market.
Key Highlights
- Splash Beverage Group invested CDN$300,000 in Avicanna Inc.
- The investment included the acquisition of 2,000,000 common shares and 1,000,000 warrants in Avicanna.
- This strategic capital allocation aligns with Splash's transformation into a cannabinoid-based health, wellness, and healthcare platform.
- Avicanna Inc. is a commercial-stage cannabinoid-based biopharmaceutical company.
- Avicanna's portfolio includes Trunerox™, an approved cannabidiol treatment, and the MyMedi.ca medical cannabis care platform.
- Splash believes Avicanna is well-positioned for the evolving medical cannabinoid market in the United States.
Price Impact
More from SBEV